Structured Evidence Transforms Target Selection at a Leading Pharma
How a global pharmaceutical company deployed Galactic Data across its discovery pipeline to improve portfolio value by hundreds of millions in expected NPV while cutting scholarship time by 72%.
From manual literature synthesis to evidence-scored target selection
A leading global pharmaceutical company needed to accelerate and deepen biological and clinical insights from publications, clinical trials and patent data at a scale and speed that manual literature review could not sustain. High target attrition rates were eroding portfolio value and increasing the cost of late-stage development failures.
Biorelate's causal knowledge graph was deployed to integrate multi-omic datasets with curated literature evidence, enabling automated hypothesis generation and target scoring. The platform provided biologists with ranked, evidence-backed target lists, reducing dependence on manual expert review.
Biorelate's causal knowledge graph was deployed to integrate multi-omic datasets with curated literature evidence, enabling automated hypothesis generation and target scoring. The platform provided biologists with ranked, evidence-backed target lists, reducing dependence on manual expert review.
See what Galactic Data can do for your pipeline
We'll run a live analysis on your target of interest and show you the evidence in minutes.